Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma.

Liu FY, Deng YL, Li Y, Zeng D, Zhou ZZ, Tian DA, Liu M.

Med Oncol. 2013 Mar;30(1):425. doi: 10.1007/s12032-012-0425-3. Epub 2013 Jan 17.

PMID:
23325444
2.

Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.

Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.

J Gastroenterol Hepatol. 2012 Jan;27(1):173-80. doi: 10.1111/j.1440-1746.2011.06847.x.

PMID:
21777276
3.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

4.

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.

Guo X, Xiong L, Sun T, Peng R, Zou L, Zhu H, Zhang J, Li H, Zhao J.

Diagn Pathol. 2012 Apr 19;7:44. doi: 10.1186/1746-1596-7-44.

5.

Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.

Chen XQ, He JR, Wang HY.

Med Oncol. 2012 Sep;29(3):1843-9. doi: 10.1007/s12032-011-0075-x. Epub 2011 Oct 11.

PMID:
21987076
6.

FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.

Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.

World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.

7.

Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma.

Zhou P, Chen Z, Chang RM, Jiang W, Wu LL, Wang ZM.

Med Oncol. 2012 Dec;29(5):3063-9. doi: 10.1007/s12032-012-0258-0. Epub 2012 May 27.

PMID:
22644917
8.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
9.

Down-regulation of formin-like 2 predicts poor prognosis in hepatocellular carcinoma.

Liang L, Guan J, Zeng Y, Wang J, Li X, Zhang X, Ding Y.

Hum Pathol. 2011 Nov;42(11):1603-12. doi: 10.1016/j.humpath.2010.08.025. Epub 2011 Apr 14.

PMID:
21496865
10.

Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.

Dai B, Ruan B, Wu J, Wang J, Shang R, Sun W, Li X, Dou K, Wang D, Li Y.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5645-54. eCollection 2014.

11.

High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.

Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M.

Pathol Oncol Res. 2013 Jan;19(1):79-88. doi: 10.1007/s12253-012-9560-6. Epub 2012 Sep 12.

PMID:
22965687
12.

Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.

Zhang X, Li N, Li X, Zhao W, Qiao Y, Liang L, Ding Y.

J Gastroenterol Hepatol. 2012 Jun;27(6):1117-25. doi: 10.1111/j.1440-1746.2011.07049.x.

PMID:
22168621
13.

Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.

Zheng J, Guo X, Gao X, Liu H, Tu Y, Zhang Y.

Clin Transl Oncol. 2014 Jan;16(1):57-63. doi: 10.1007/s12094-013-1040-2. Epub 2013 Apr 30.

PMID:
23632812
14.

Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.

Ye WC, Gao L, Huang J, Fang XM, Xie G.

Mol Med Rep. 2014 Oct;10(4):2087-92. doi: 10.3892/mmr.2014.2429. Epub 2014 Jul 29.

PMID:
25109837
15.

High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.

Li M, Luo RZ, Chen JW, Cao Y, Lu JB, He JH, Wu QL, Cai MY.

J Transl Med. 2011 Jan 5;9:5. doi: 10.1186/1479-5876-9-5.

16.

High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.

Jiang W, Wang Z, Li X, Fan X, Duan Y.

Pathol Oncol Res. 2012 Apr;18(2):293-8. doi: 10.1007/s12253-011-9442-3. Epub 2011 Sep 7.

PMID:
21953322
17.

Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.

Li SX, Tang GS, Zhou DX, Pan YF, Tan YX, Zhang J, Zhang B, Ding ZW, Liu LJ, Jiang TY, Hu HP, Dong LW, Wang HY.

Cancer. 2014 May 15;120(10):1520-31. doi: 10.1002/cncr.28593. Epub 2014 Feb 22.

18.

Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.

Qiu X, Zheng J, Guo X, Gao X, Liu H, Tu Y, Zhang Y.

Mol Cell Biochem. 2013 Jun;378(1-2):99-106. doi: 10.1007/s11010-013-1599-5. Epub 2013 Mar 11.

PMID:
23475171
19.

Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma.

Lu JW, Lin YM, Chang JG, Yeh KT, Chen RM, Tsai JJ, Su WW, Hu RM.

Med Oncol. 2013 Mar;30(1):379. doi: 10.1007/s12032-012-0379-5. Epub 2013 Jan 5.

PMID:
23292829
20.

MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.

Wang J, Li J, Shen J, Wang C, Yang L, Zhang X.

BMC Cancer. 2012 Jun 8;12:227. doi: 10.1186/1471-2407-12-227.

Supplemental Content

Support Center